top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
EMC1501
Endometrial cancer tissue array, set 1, non-overlapping with EMC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Price per slide:
$289
Species:
Human
Cases:
75
Cores:
150
Core Size:
1.1mm
Core Thickness:
4um
Rows:
10
Columns:
15
Format:
Intended Usage:
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in various endometrium cancers.
10
X
15
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 52 | Uterus, endometrium | Normal | Normal | ||
A02 |  | F | 45 | Uterus, endometrium | Normal | Normal | ||
A03 |  | F | 31 | Uterus, endometrium | Normal | Normal | ||
A04 |  | F | 53 | Uterus, endometrium | Atypical hyperplasia | Hyperplasia | ||
A05 |  | F | 63 | Uterus, endometrium | Atypical hyperplasia | Hyperplasia | ||
A06 |  | F | 44 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
A07 |  | F | 62 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N1M0 |
A08 |  | F | 56 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | T1N0M0 | |
A09 |  | F | 56 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
A10 |  | F | 56 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
A11 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T2N1M0 |
A12 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N1M0 |
A13 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N0M0 |
A14 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T2N0M0 |
A15 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
B01 |  | F | 52 | Uterus, endometrium | Normal | Normal | ||
B02 |  | F | 45 | Uterus, endometrium | Normal | Normal | ||
B03 |  | F | 31 | Uterus, endometrium | Normal | Normal | ||
B04 |  | F | 53 | Uterus, endometrium | Atypical hyperplasia | Hyperplasia | ||
B05 |  | F | 63 | Uterus, endometrium | Atypical hyperplasia | Hyperplasia | ||
B06 |  | F | 44 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
B07 |  | F | 62 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N1M0 |
B08 |  | F | 56 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | T1N0M0 | |
B09 |  | F | 56 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
B10 |  | F | 56 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
B11 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T2N1M0 |
B12 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N1M0 |
B13 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N0M0 |
B14 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T2N0M0 |
B15 | | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
C01 |  | F | 46 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
C02 |  | F | 78 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N1M0 |
C03 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
C04 |  | F | 49 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T3N1M0 |
C05 |  | F | 47 | Uterus, endometrium | Squamous cell carcinoma | Malignant | I | T1N0M0 |
C06 |  | F | 55 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T2N1M0 |
C07 |  | F | 74 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
C08 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
C09 |  | F | 36 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
C10 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
C11 |  | F | 59 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
C12 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N1M0 |
C13 |  | F | 40 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N1M0 |
C14 |  | F | 70 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T2N0M0 |
C15 |  | F | 54 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N0M0 |
D01 |  | F | 46 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
D02 |  | F | 78 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N1M0 |
D03 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
D04 |  | F | 49 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T3N1M0 |
D05 |  | F | 47 | Uterus, endometrium | Squamous cell carcinoma | Malignant | I | T1N0M0 |
D06 |  | F | 55 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T2N1M0 |
D07 |  | F | 74 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
D08 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
D09 |  | F | 36 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
D10 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
D11 |  | F | 59 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
D12 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N1M0 |
D13 |  | F | 40 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N1M0 |
D14 |  | F | 70 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T2N0M0 |
D15 |  | F | 54 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N0M0 |
E01 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
E02 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
E03 |  | F | 63 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
E04 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
E05 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
E06 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N0M0 |
E07 |  | F | 70 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | III | T1N0M0 |
E08 |  | F | 68 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
E09 |  | F | 56 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | T1N0M0 | |
E10 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N1M0 |
E11 |  | F | 53 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | III | T2N1M0 |
E12 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
E13 |  | F | 52 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N0M0 |
E14 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
E15 |  | F | 50 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N1M0 |
F01 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
F02 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
F03 |  | F | 63 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
F04 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
F05 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
F06 |  | F | 48 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N0M0 |
F07 |  | F | 70 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | III | T1N0M0 |
F08 |  | F | 68 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
F09 |  | F | 56 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | T1N0M0 | |
F10 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N1M0 |
F11 |  | F | 53 | Uterus, endometrium | Adenosquamous carcinoma | Malignant | III | T2N1M0 |
F12 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
F13 |  | F | 52 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T1N0M0 |
F14 |  | F | 41 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
F15 |  | F | 50 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N1M0 |
G01 |  | F | 55 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
G02 |  | F | 53 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T3N0M0 | |
G03 |  | F | 50 | Uterus, endometrium | Endometrial stromal sarcoma | Malignant | T1N0M0 | |
G04 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
G05 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
G06 |  | F | 49 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
G07 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N0M0 |
G08 |  | F | 54 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
G09 |  | F | 36 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T1N0M0 | |
G10 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
G11 |  | F | 45 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
G12 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
G13 |  | F | 68 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
G14 |  | F | 39 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T2N0M0 |
G15 |  | F | 44 | Uterus, endometrium | Stromal sarcoma | Malignant | ||
H01 |  | F | 55 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
H02 |  | F | 53 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T3N0M0 | |
H03 |  | F | 50 | Uterus, endometrium | Endometrial stromal sarcoma | Malignant | T1N0M0 | |
H04 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
H05 |  | F | 53 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | I~II | T1N0M0 |
H06 |  | F | 49 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
H07 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N0M0 |
H08 |  | F | 54 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
H09 |  | F | 36 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T1N0M0 | |
H10 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
H11 |  | F | 45 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
H12 |  | F | 51 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
H13 |  | F | 68 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
H14 |  | F | 39 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T2N0M0 |
H15 |  | F | 44 | Uterus, endometrium | Stromal sarcoma | Malignant | ||
I01 |  | F | 46 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
I02 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T2N0M0 |
I03 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T3N0M0 |
I04 |  | F | 67 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T2N0M0 |
I05 |  | F | 51 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T1N1M0 | |
I06 |  | F | 42 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
I07 |  | F | 52 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
I08 |  | F | 66 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T1N0M0 | |
I09 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T3N0M0 |
I10 |  | F | 54 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
I11 |  | F | 33 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N0M0 |
I12 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
I13 |  | F | 58 | Uterus, endometrium | Squamous cell carcinoma | Malignant | II~III | T1N0M0 |
I14 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
I15 |  | F | 40 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N0M0 |
J01 |  | F | 46 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
J02 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | II~III | T2N0M0 |
J03 |  | F | 53 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T3N0M0 |
J04 |  | F | 67 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T2N0M0 |
J05 |  | F | 51 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T1N1M0 | |
J06 |  | F | 42 | Uterus, endometrium | Adenocarcinoma | Malignant | I | T1N0M0 |
J07 |  | F | 52 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T1N0M0 |
J08 |  | F | 66 | Uterus, endometrium | Undifferentiated carcinoma | Malignant | T1N0M0 | |
J09 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | III | T3N0M0 |
J10 |  | F | 54 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
J11 |  | F | 33 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T2N0M0 |
J12 |  | F | 60 | Uterus, endometrium | Adenocarcinoma | Malignant | I~II | T1N0M0 |
J13 |  | F | 58 | Uterus, endometrium | Squamous cell carcinoma | Malignant | II~III | T1N0M0 |
J14 |  | F | 43 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T1N0M0 |
J15 |  | F | 40 | Uterus, endometrium | Adenocarcinoma | Malignant | II | T2N0M0 |
bottom of page